Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating or delaying progression of an epidermal growth factor receptor (EGFR)-related disorder by administering activatable EGFR-binding antibodies

Method of treating or delaying progression of an epidermal growth factor receptor (EGFR)-related disorder by administering activatable EGFR-binding antibodies

US Patent 11180562 · Granted Nov 23, 2021

Estimated economic value: $6,214,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Activatable antibodies that bind epidermal growth factor receptor and methods of2025
Activatable antibodies that bind epidermal growth factor receptor and methods of2025
Methods of qualitatively and/or quantitatively analyzing properties of activatab2025
Method of using an anti-epidermal growth factor receptor (EGFR) activatable anti2024
Method of using an anti-epidermal growth factor receptor (EGFR) activatable anti2024
Method of using an anti-epidermal growth factor receptor (EGFR) activatable anti2024
Compositions and methods for conjugating activatable antibodies2024
Compositions and methods for conjugating activatable antibodies2024
Activatable antibodies that bind epidermal growth factor receptor and methods th2024
Activatable antibodies that bind epidermal growth factor receptor and methods th2024
Activatable antibodies that bind epidermal growth factor receptor and methods th2024
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use the2023